- Home
- CALC vs GTEC Comparison
CALC vs GTEC Comparison
Compare CALC & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- GTEC
- Stock Information
- Founded
- CALC 2011
- GTEC 2006
- Country
- CALC United States
- GTEC United States
- Employees
- CALC N/A
- GTEC N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- GTEC Industrial Machinery/Components
- Sector
- CALC Health Care
- GTEC Industrials
- Exchange
- CALC Nasdaq
- GTEC Nasdaq
- Market Cap
- CALC 22.9M
- GTEC 19.7M
- IPO Year
- CALC N/A
- GTEC N/A
- Fundamental
- Price
- CALC $1.58
- GTEC $2.02
- Analyst Decision
- CALC Strong Buy
- GTEC
- Analyst Count
- CALC 3
- GTEC 0
- Target Price
- CALC $16.33
- GTEC N/A
- AVG Volume (30 Days)
- CALC 28.9K
- GTEC 100.5K
- Earning Date
- CALC 08-11-2025
- GTEC 08-14-2025
- Dividend Yield
- CALC N/A
- GTEC N/A
- EPS Growth
- CALC N/A
- GTEC N/A
- EPS
- CALC N/A
- GTEC 1.14
- Revenue
- CALC N/A
- GTEC $82,898,634.00
- Revenue This Year
- CALC N/A
- GTEC $3.28
- Revenue Next Year
- CALC N/A
- GTEC N/A
- P/E Ratio
- CALC N/A
- GTEC $1.76
- Revenue Growth
- CALC N/A
- GTEC N/A
- 52 Week Low
- CALC $1.42
- GTEC $1.17
- 52 Week High
- CALC $5.97
- GTEC $2.94
- Technical
- Relative Strength Index (RSI)
- CALC 44.94
- GTEC 47.93
- Support Level
- CALC $1.42
- GTEC $2.05
- Resistance Level
- CALC $1.85
- GTEC $2.26
- Average True Range (ATR)
- CALC 0.15
- GTEC 0.11
- MACD
- CALC -0.01
- GTEC -0.02
- Stochastic Oscillator
- CALC 37.21
- GTEC 22.36
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.